11-07-2025
Berenberg Bank Remains a Hold on Novartis AG (NOVN)
In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Hold rating on Novartis AG, with a price target of CHF89.00. The company's shares opened today at CHF97.91.
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
According to TipRanks, Holford is a 4-star analyst with an average return of 11.9% and a 62.65% success rate. Holford covers the Healthcare sector, focusing on stocks such as Novartis AG, GlaxoSmithKline, and GlaxoSmithKline.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Novartis AG with a CHF102.73 average price target, which is a 4.92% upside from current levels. In a report released on July 4, UBS also maintained a Hold rating on the stock with a CHF104.00 price target.
The company has a one-year high of CHF102.72 and a one-year low of CHF81.10. Currently, Novartis AG has an average volume of 3.31M.
